Two million Americans are allergic to insect stings, an allergy which sends more than 500,000 people to the emergency room annually. Yet, according to a study published today in the March issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAA), while fire ant allergy sufferers know allergy shots can save their life, more than 60 percent do not adhere to treatment guidelines.
For optimal protection against fire ant stings, allergists recommend allergy shots, also known as immunotherapy, be administered monthly. With this course of treatment, it has been proven allergy shots can modify and prevent disease progression. It can also lessen the chance for anaphylaxis, a severe allergic reaction that can be deadly.
"Our research found only 35 percent of fire ant allergic respondents adhered to treatment guidelines after one year," said allergist Shayne Stokes, MD, ACAAI member and lead study author. "Inconvenience and fear were reported as reasons why the recommendations were not followed."
Immunotherapy is currently the only disease-modifying treatment available for fire ant stings, and other allergies, within the United States.
"Immunotherapy is proven to be safe and efficient at treating allergic diseases," said Dr. Stokes. "It can also result in health care savings of 33 to 41 percent. Allergists are specialists in administering these injections which can cure patients of symptoms and prevent the development of other allergies and severe allergic reactions."
According to the ACAAI, fire ants are common throughout the southeastern United States. People who have had an allergic reaction to a sting in the past have a 60 percent chance of receiving a similar or more severe reaction if stung again. Sting attack rates have been reported as high as 50 percent, even for individuals only briefly visiting fire ant regions.
Those who experience an allergic reaction should seek help immediately and follow up with an allergist. An allergist might prescribe allergy shots and life-saving epinephrine.
For more information about allergies and immunotherapy, or to locate an allergist in your area to find relief, please visit www.AllergyAndAsthmaRelief.org.
The ACAAI is a professional medical organization of more than 5,700 allergists-immunologists and allied health professionals, headquartered in Arlington Heights, Ill. The College fosters a culture of collaboration and congeniality in which its members work together and with others toward the common goals of patient care, education, advocacy and research. ACAAI allergists are board-certified physicians trained to diagnose allergies and asthma, administer immunotherapy, and provide patients with the best treatment outcomes. For more information and to find relief, visit www.AllergyAndAsthmaRelief.org. Join us on Facebook, Pinterest and Twitter.
Christine Westendorf | EurekAlert!
Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University
The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
05.12.2016 | Power and Electrical Engineering
05.12.2016 | Materials Sciences
05.12.2016 | Power and Electrical Engineering